• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

复方更年康对更年期雌性大鼠性激素及骨组织雌激素受体表达的影响

[Effect of compound recipe Gengniankang on senile sexual hormone and expression of estrogen receptor in bone of climacteric female rats].

作者信息

Wu Su-hui, Sun Jing-fen, Guo Shu-zhen

机构信息

Department of Obstetrics and Gynecology, The First Hospital, Shanxi Medical University, Taiyuan 030001, China.

出版信息

Chin J Integr Med. 2005 Sep;11(3):205-8. doi: 10.1007/BF02836506.

DOI:10.1007/BF02836506
PMID:16181536
Abstract

OBJECTIVE

To compare the therapeutic effect of Compound Recipe Gengniankang ( GNK) with that of hormone replacement treatment (HRT) on climacteric female rats with osteoporosis, and to investigate the roles of estrogen and estrogen receptors in the mechanism of osteoporosis.

METHODS

Climacteric female rats with osteoporosis were chosen and divided into three groups (GNK group, HRT group and control group). Apoptosis of ovarian granulose cells was measured by terminal-deoxynucleotidyl transferase mediated nick end labeling (TUNEL) assay. Serum level of estradiol (E(2)), follicle stimulating hormone (FSH), luteinizing hormone (LH) were determined by the method of radioimmunoassay (RIA). Reverse transcriptase polymerase chain reaction (RT-PCT) technology was used to evaluate the expression of estrogen receptor (ER) in bone. Bone mineral density (BMD) was measured by double energy X-ray absorption (DEXA).

RESULTS

In the climacteric rats, BMD, serum E(2), ER mRNA expression in bone decreased remarkably, and serum FSH, LH and apoptosis of ovarian granulose cells increased obviously. After treating with GNK, all the indexes were reversed except serum E(2). The increase of E(2) was not significant.

CONCLUSION

GNK is effective on climacteric osteoporosis female rats. Its role is performed not by increasing serum E(2) but by enhancing ER in the bone and inhibiting apoptosis of ovarian granulose cells. GNK can deter further exhaustion of ovarian function.

摘要

目的

比较复方更年康(GNK)与激素替代疗法(HRT)对绝经后骨质疏松雌性大鼠的治疗效果,并探讨雌激素及雌激素受体在骨质疏松发病机制中的作用。

方法

选取绝经后骨质疏松雌性大鼠,分为三组(GNK组、HRT组和对照组)。采用末端脱氧核苷酸转移酶介导的缺口末端标记法(TUNEL)检测卵巢颗粒细胞凋亡。采用放射免疫分析法(RIA)测定血清雌二醇(E₂)、卵泡刺激素(FSH)、黄体生成素(LH)水平。采用逆转录聚合酶链反应(RT-PCR)技术评估骨组织中雌激素受体(ER)的表达。采用双能X线吸收法(DEXA)测量骨密度(BMD)。

结果

绝经后大鼠骨密度、血清E₂、骨组织ER mRNA表达显著降低,血清FSH、LH及卵巢颗粒细胞凋亡明显增加。给予GNK治疗后,除血清E₂外,其余指标均逆转。E₂升高不显著。

结论

GNK对绝经后骨质疏松雌性大鼠有效。其作用机制不是通过升高血清E₂,而是通过增强骨组织中ER表达及抑制卵巢颗粒细胞凋亡来实现的。GNK可延缓卵巢功能的进一步衰退。

相似文献

1
[Effect of compound recipe Gengniankang on senile sexual hormone and expression of estrogen receptor in bone of climacteric female rats].复方更年康对更年期雌性大鼠性激素及骨组织雌激素受体表达的影响
Chin J Integr Med. 2005 Sep;11(3):205-8. doi: 10.1007/BF02836506.
2
[Experimental study on regulatory effect of compound gengniankang on endocrine and immune functions in aged female rats with osteoporosis].
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2004 Jun;24(6):545-8.
3
Effect of a derived herbal recipe from an ancient Chinese formula, Danggui Buxue Tang, on ovariectomized rats.当归补血汤衍生草药配方对去卵巢大鼠的影响。
J Ethnopharmacol. 2012 Dec 18;144(3):567-75. doi: 10.1016/j.jep.2012.09.041. Epub 2012 Oct 2.
4
The effect of ovarian steroid feedback upon radioimmunoreactive luteinizing hormone releasing hormone in the hypothalamus.卵巢甾体反馈对下丘脑放射免疫活性促黄体生成激素释放激素的影响。
Endocrinol Jpn. 1975 Dec;22(6):525-30. doi: 10.1507/endocrj1954.22.525.
5
Correlation between climacteric symptoms and serum levels of estradiol, progesterone, follicle-stimulating hormone, and luteinizing hormone.更年期症状与血清雌二醇、孕酮、促卵泡激素及促黄体生成素水平之间的相关性。
Am J Obstet Gynecol. 1977 Sep 1;129(1):65-7. doi: 10.1016/0002-9378(77)90822-5.
6
Serum follicle-stimulating hormone level is a predictor of bone mineral density in patients with hormone replacement therapy.血清促卵泡激素水平是接受激素替代疗法患者骨密度的一个预测指标。
Arch Gynecol Obstet. 2004 Mar;269(3):192-5. doi: 10.1007/s00404-003-0532-7. Epub 2003 Sep 12.
7
Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.绝经前垂体与卵巢的关系。I. 血清卵泡刺激素、黄体生成素、催乳素、雌二醇和孕酮水平的横断面研究。
Am J Obstet Gynecol. 1977 Nov 1;129(5):557-64.
8
Follicle-Stimulating Hormone Increases the Risk of Postmenopausal Osteoporosis by Stimulating Osteoclast Differentiation.促卵泡激素通过刺激破骨细胞分化增加绝经后骨质疏松症的风险。
PLoS One. 2015 Aug 4;10(8):e0134986. doi: 10.1371/journal.pone.0134986. eCollection 2015.
9
[Effect of kidney-replenishing herbs on ovarian function of dexamethasone-induced osteoporosis in rats].
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2000 Jan;20(1):46-9.
10
Levels of follicle-stimulating hormone, luteinizing hormone, oestradiol-17 beta and progesterone, and follicular growth in the pseudopregnant rat.假孕大鼠体内促卵泡激素、黄体生成素、雌二醇-17β和孕酮水平以及卵泡生长情况
J Endocrinol. 1975 Jan;64(1):37-47. doi: 10.1677/joe.0.0640037.

引用本文的文献

1
Kuntai Capsule plus Hormone Therapy vs. Hormone Therapy Alone in Patients with Premature Ovarian Failure: A Systematic Review and Meta-Analysis.坤泰胶囊联合激素治疗与单纯激素治疗对卵巢早衰患者的疗效:一项系统评价和Meta分析
Evid Based Complement Alternat Med. 2019 Jun 26;2019:2085804. doi: 10.1155/2019/2085804. eCollection 2019.
2
Efficacy and safety investigation of Kuntai capsule for the add-back therapy of gonadotropin releasing hormone agonist administration to endometriosis patients: a randomized, double-blind, blank- and tibolone-controlled study.坤泰胶囊对子宫内膜异位症患者促性腺激素释放激素激动剂给药进行反向添加治疗的疗效与安全性研究:一项随机、双盲、空白及替勃龙对照研究
Chin Med J (Engl). 2015 Feb 20;128(4):427-32. doi: 10.4103/0366-6999.151057.
3

本文引用的文献

1
Selective estrogen-receptor modulators -- mechanisms of action and application to clinical practice.选择性雌激素受体调节剂——作用机制及其在临床实践中的应用
N Engl J Med. 2003 Feb 13;348(7):618-29. doi: 10.1056/NEJMra022219.
2
ACOG practice bulletin. Selective estrogen receptor modulators. Number 39, October 2002 (replaces Committee Opinion Number 224, October 1999).
Int J Gynaecol Obstet. 2002 Dec;79(3):289-98. doi: 10.1016/s0020-7292(02)00350-8.
3
[Specific estrogen receptor modulators (SERMs)].[特异性雌激素受体调节剂(SERMs)]
Combining ZHENG Theory and High-Throughput Expression Data to Predict New Effects of Chinese Herbal Formulae.结合证理论和高通量表达数据预测中药方剂的新作用。
Evid Based Complement Alternat Med. 2012;2012:986427. doi: 10.1155/2012/986427. Epub 2012 May 14.
Presse Med. 2002 Sep 7;31(28):1323-8.
4
Selective estrogen receptor modulators: tissue actions and potential for CNS protection.选择性雌激素受体调节剂:组织作用及中枢神经系统保护潜力
CNS Drug Rev. 2002 Fall;8(3):309-30. doi: 10.1111/j.1527-3458.2002.tb00230.x.
5
Adverse events that are associated with the selective estrogen receptor modulator levormeloxifene in an aborted phase III osteoporosis treatment study.在一项已中止的III期骨质疏松症治疗研究中,与选择性雌激素受体调节剂左美洛昔芬相关的不良事件。
Am J Obstet Gynecol. 2002 Sep;187(3):521-7. doi: 10.1067/mob.2002.123938.
6
HRT and SERMs: the good, the bad...and the lovely?
Trends Endocrinol Metab. 2002 Oct;13(8):317-8. doi: 10.1016/s1043-2760(02)00674-4.
7
Serum estradiol level and risk of breast cancer during treatment with raloxifene.雷洛昔芬治疗期间的血清雌二醇水平与乳腺癌风险
JAMA. 2002 Jan 9;287(2):216-20. doi: 10.1001/jama.287.2.216.
8
Effect of raloxifene on breast cancer cell Ki67 and apoptosis: a double-blind, placebo-controlled, randomized clinical trial in postmenopausal patients.雷洛昔芬对乳腺癌细胞Ki67及细胞凋亡的影响:一项针对绝经后患者的双盲、安慰剂对照、随机临床试验。
Cancer Epidemiol Biomarkers Prev. 2001 Sep;10(9):961-6.
9
Risks and benefits of soy phytoestrogens in cardiovascular diseases, cancer, climacteric symptoms and osteoporosis.大豆植物雌激素在心血管疾病、癌症、更年期症状及骨质疏松症中的风险与益处。
Drug Saf. 2001;24(9):665-82. doi: 10.2165/00002018-200124090-00003.
10
[Phytoestrogens and SERMS, alternatives to classical hormone therapy?].[植物雌激素和选择性雌激素受体调节剂,传统激素疗法的替代方案?]
Ther Umsch. 2000 Oct;57(10):651-4. doi: 10.1024/0040-5930.57.10.651.